New York A05882 mandates pharmacy benefit managers to pay pharmacies at least the national average drug acquisition cost, or the pharmacy acquisition.

New York A05882 amends the public health and insurance laws to establish minimum payment standards for pharmacy benefit managers. These managers must pay participating pharmacies at least the national average drug acquisition cost (NADAC) rate, or the pharmacy acquisition cost if higher or there is no NADAC rate, plus a professional dispensing fee. The professional dispensing fee must be at least the fee paid under the state medical assistance program. This applies to generic, brand name, biologic products, and drugs produced through genetic technology or biopharmaceutical processes.

New York A05882 mandates pharmacy benefit managers to pay pharmacies at least the national average drug acquisition cost, or the pharmacy acquisition.

New York A05882 amends the public health and insurance laws to establish minimum payment standards for pharmacy benefit managers. These managers must pay participating pharmacies at least the national average drug acquisition cost (NADAC) rate, or the pharmacy acquisition cost if higher or there is no NADAC rate, plus a professional dispensing fee. The professional dispensing fee must be at least the fee paid under the state medical assistance program. This applies to generic, brand name, biologic products, and drugs produced through genetic technology or biopharmaceutical processes.